NEW YORK (GenomeWeb) – PerkinElmer announced Tuesday it has signed an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission to create and implement a newborn screening training program focused on rural China.

Under the three-year agreement, PerkinElmer will provide its diagnostic tests and expertise to develop and roll out a program that will "substantially increase adoption and access to newborn screening in China," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.